6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
ID: 36C77025Q0060Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/322baccb757c4124a844d5fe95458325/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.

    Point(s) of Contact
    Blackard, Jeffrey A.TCF Intern
    (913) 684-0142
    Jeffrey.Blackard@va.gov
    Files
    Title
    Posted
    36C77025Q0060_1.docx
    The document outlines a government Request for Proposal (RFP) for pharmaceutical supplies, specifically from the Department of Veterans Affairs (VA). It includes key details such as the acquisition's unrestricted or set-aside nature for various small business categories and the necessary documentation for submission, including a signed SF 1449 form and a completed price schedule. The delivery terms emphasize that all products must be shippable via USPS, adherence to the Drug Supply Chain Security Act (DSCSA), and requirements for barcoding. The RFP also details contract clauses and conditions under which the contract will be administered, establishing stipulations for payment processing, contract changes, and termination processes. The document underscores the necessity for compliance with federal regulations and emphasizes the need for accurate invoicing and tracking of contracts. It seeks to enhance the efficiency and accountability of the procurement process while ensuring that products supplied meet stringent regulatory standards. Overall, this RFP is part of the VA's commitment to securing reliable pharmaceutical supplies while promoting compliance and operational transparency within federal procurement practices.
    36C77025Q0060.docx
    The Department of Veterans Affairs is seeking to procure Mirtazapine (7.5MG tablets, 30 count) through a presolicitation notice for the Tucson CMOP facility. The solicitation number is 36C77025Q0060, with a closing response date of December 27, 2024, at 9:00 AM CST. This opportunity is set aside for small businesses. Vendors are required to submit detailed proposals consisting of a signed SF1449 cover page, a price schedule in Excel format, a valid state wholesale distributor license, and a completed Buy American certificate. The estimated award date is December 31, 2024, with a delivery timeframe of ten days after receipt of order (ARO). The procurement is subject to the Buy American statute, emphasizing the need for domestic product quotes if applicable. Offerors must comply with the Drug Supply Chain Security Act (DSCSA) by submitting their state license alongside their quote. All submissions must be directed to the designated VA point of contact via email. The document underscores the importance of compliance, pricing structure, and the necessity for monitoring updates on the solicitation through Contract Opportunities at sam.gov.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The document outlines the "Buy American Certificate" requirements as part of federal procurement practices. It stipulates that Offerors must certify that their end products are domestic unless otherwise noted. The Offeror is required to list foreign products, identifying their country of origin and indicating if they exceed 55% domestic content, except for commercially available off-the-shelf (COTS) items. Additionally, Offerors must separately specify domestic end products that contain critical components. The government's evaluation of offers will follow the Federal Acquisition Regulation (FAR) part 25 policies and procedures. This provision emphasizes the federal government's commitment to supporting domestic manufacturing and ensuring that awarded contracts contribute positively to the U.S. economy while maintaining compliance with specified standards.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0060.xlsx
    This document pertains to a Request for Quote (RFQ) from the Veterans Affairs (VA) for the procurement of Mirtazapine 7.5mg tablets. The estimated issue date is December 18, 2024, with a response deadline of December 27, 2024. Awards are expected by December 31, 2024, and delivery is required by January 15, 2025. Suppliers must comply with the Drug Supply Chain Security Act (DSCSA) and submit their state wholesale distributor license alongside their quotes to verify compliance. The document also outlines required submissions, including a signed SF1449 cover page, a price schedule, and a completed Buy American Certificate. Communication regarding submissions should be directed to specific VA procurement emails, depending on the distribution center. The document emphasizes the importance of DSCSA adherence, listing the potential consequences of non-compliance, while also specifying shipping addresses for various CMOP locations across the United States. The overall aim is to ensure a reliable drug supply compliant with federal regulations for the benefit of VA health programs.
    Similar Opportunities
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0059 762-25-1-040-0124 -Tucson CMOP ATORVASTATIN CALCIUM -(VA-25-00015524)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Atorvastatin Calcium 80mg tablets to be delivered to its Tucson CMOP facility. This contract is specifically set aside for small businesses and requires compliance with the Buy American statute, necessitating separate quotes for foreign and domestic products. The pharmaceuticals are critical for the healthcare of veterans, emphasizing the importance of responsible sourcing and regulatory compliance in the pharmaceutical supply chain. Interested vendors must submit their proposals via email to Jeffrey Blackard by December 26, 2024, at 09:00 AM Central Time, with the anticipated award date set for December 30, 2024.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires bidders to provide pricing for the base year and four option years, ensuring compliance with current Good Manufacturing Practices (cGMP) and adherence to FDA regulations, including drug registration and barcoding requirements. This procurement is crucial for maintaining the supply of essential medications for VA healthcare needs. Interested parties must submit their offers by December 24, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.